Mobilizing Dendritic Cells for Tolerance, Priming, and Chronic Inflammation
Open Access
- 15 February 1999
- journal article
- editorial
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 189 (4) , 611-614
- https://doi.org/10.1084/jem.189.4.611
Abstract
No abstract availableThis publication has 33 references indexed in Scilit:
- Dendritic Cells Induce Autoimmune Diabetes and Maintain Disease via De Novo Formation of Local Lymphoid TissueThe Journal of Experimental Medicine, 1998
- T cell response to Epstein-Barr virus transactivators in chronic rheumatoid arthritis.The Journal of Experimental Medicine, 1996
- Chronic inflammation caused by lymphotoxin is lymphoid neogenesis.The Journal of Experimental Medicine, 1996
- Immunology Taught by VirusesScience, 1996
- Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products.The Journal of Experimental Medicine, 1995
- Antigen-independent activation of naive and memory resting T cells by a cytokine combination.The Journal of Experimental Medicine, 1994
- Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha.The Journal of Experimental Medicine, 1994
- Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigmCell, 1994
- GMP-140, a platelet alpha-granule membrane protein, is also synthesized by vascular endothelial cells and is localized in Weibel-Palade bodies.Journal of Clinical Investigation, 1989
- THE ORIGIN AND KINETICS OF MONONUCLEAR PHAGOCYTESThe Journal of Experimental Medicine, 1968